在细胞培养中,VP4突变促进了复合人/猿罗塔病毒在细胞培养中的复制
Roman Valusenko-Mehrkens1, Katja Schilling-Loeffler1, Reimar Johne1
1Department of Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.
Viruses
|April 27, 2024
概括
开发新的罗塔病毒A疫苗至关重要. VP4蛋白中的特定突变显著改善了细胞培养中的重组轮状病毒的救援和复制,有助于疫苗的开发.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 罗塔病毒A (RVA) 是严重腹和儿童死亡的主要原因,特别是在撒哈拉以南非洲.
- 目前的疫苗开发旨在针对不同的非洲RVA基因型.
研究的目的:
- 使用反向遗传系统生成下一代针对非洲基因型的RVA疫苗.
- 为了提高在细胞培养中重新组合RVA菌株的救援和复制效率.
主要方法:
- 使用猿类轮状病毒逆遗传系统,将VP4,VP7和VP6基因与非洲人类RVA菌株的基因交换.
- 通过全基因组测序来拯救,传递和分析重组病毒.
- 用于引入特定的VP4突变,使用了局部导向的突变发生.
主要成果:
- 一个G9-P[6]-I2三重复合RVA最初显示复制不良,但通过后得到改善.
- 全基因组测序确定了VP4 (E263G) 中的一个单点突变 (A797G),该突变负责增强复制.
- 将这种突变引入VP4等离子体显著增加了单重组和三重组病毒的复制.
- 突变的有益影响是菌株特异性的.
结论:
- 在VP4蛋白中的特定点突变可以大大提高细胞培养中的重组RVA复合物的救援和复制.
- 这一发现对于开发新型RVA疫苗菌株,特别是针对流行非洲基因型的新型疫苗有价值.
相关概念视频
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K


